Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Report: UnitedHealth rewarded nursing homes for delaying hospital transfers
Citing evidence from documents and interviews, the Guardian released an exposé accusing UnitedHealth of directly influencing the day-to-day operations of some 2,000 nursing homes, resulting in patients not receiving necessary emergency care.
FDA wants new heart damage warnings added to COVID-19 vaccines
COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.
Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
Work begins on first ATTR-CM study of its kind
ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.
FDA outlines stricter ‘evidence-based approach’ to COVID vaccinations
The FDA is revising its approach to COVID-19 vaccine approvals, moving away from the previous trend of treating boosters like annual flu shots. Health researcher Vinay Prasad and Commissioner Martin Makary argue in the New England Journal of Medicine for more rigorous data requirements and additional clinical studies to justify future inoculations for those under 65.

AI predicts LBBB risk in TAVR patients prior to treatment

The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.

Srihari S. Naidu, MD, FACC, FAHA, MSCAI, assumed the role of president of the Society for Cardiovascular Angiography and Interventions (SCAI) May 3 during the society's annual meeting. He outlined his ambitious plans to take SCAI in some new directions. #SCAI #SCAI2025

New SCAI president lists advocacy, cardiogenic shock among his top priorities

Srihari Naidu, MD, spoke to Cardiovascular Business about his plan to take SCAI in some bold new directions.

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.

cannabis use disorder marijuana joint weed smoking

Consistent cannabis use linked to multiple cardiovascular risks for heart failure patients

Cannabis use can be especially harmful for heart failure patients, according to new data presented at SCAI 2025.

A super alternative: BATMAN helps cardiologists limit complications during TMVR

The BATMAN technique is a safe, effective way to prevent LVOT obstruction during high-risk transcatheter mitral valve replacement, according to new data presented at SCAI 2025.

‘A defining moment’: How cardiologists can get the most out of CT-guided PCI

SCAI and SCCT have collaborated on a new document designed to get more interventional cardiologists to embrace CT-guided PCI going forward.

Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

New data question the role radiation therapy plays in cardiovascular health

There has been back-and-forth among experts on the relationship between breast arterial calcifications and cardiovascular disease for many years.

Clinical

Report: UnitedHealth rewarded nursing homes for delaying hospital transfers

FDA wants new heart damage warnings added to COVID-19 vaccines

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Work begins on first ATTR-CM study of its kind

FDA outlines stricter ‘evidence-based approach’ to COVID vaccinations